Tecan Group
Tecan Group AG is a Swiss healthcare technology enterprise headquartered in Mannedorf, Switzerland. The firm develops, manufactures, and distributes laboratory automation instruments, liquid handling workstations, and biological detection devices for life science laboratories. Its product offerings encompass automated pipetting platforms, microplate readers, genomics instruments, and specialized consumable components. Principal revenue is derived from selling laboratory equipment, software licenses, and related consumable assay products directly to research institutions and diagnostics firms. The enterprise serves pharmaceutical developers, biotechnology companies, and clinical diagnostics laboratories worldwide. Tecan Group AG is listed on the SIX Swiss Exchange.
12 of the funds FundTelligence covers report a position in Tecan Group.
- Legal name
- Tecan Group AG
- Sector
- Health Care
- Country
- Switzerland
- Funds holding it
- 12
Funds holding Tecan Group
- Fidelity Switzerland Fund — Fidelity · 4.6 % (largest positions only, October 2026)
- Nordea European Small and Mid Cap Sustainable Stars — Nordea Funds · 1.74 % (full portfolio disclosed, July 2026)
- SEB Europafond — SEB · 1.46 % (full portfolio disclosed, June 2026)
- T. Rowe Price European Smaller Companies Equity — T. Rowe Price · 1.18 % (full portfolio disclosed, September 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.4 % (full portfolio disclosed, October 2026)
- Nordea BetaPlus Enhanced Global Sustainable Small Cap — Nordea Funds · 0.23 % (full portfolio disclosed, September 2026)
- Handelsbanken Global SMB Index Criteria — Handelsbanken · 0.05 % (full portfolio disclosed, October 2026)
- DNB Global Enhanced Small Cap — DNB · 0.05 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 12 funds holding it.